106 results
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
29 May 24
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
5:00pm
in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
23 May 24
Regulation FD Disclosure
5:20pm
the dramatic increase in cheating. This is a growing concern and cannot continue, as the safety of each individual exposed to these employees … in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
20 May 24
Regulation FD Disclosure
5:00pm
Exhibit 99.1
Innovative Fingerprint Drug Screening Solution Showcased at the UK’s Premier Health and Safety Event
NEW YORK, May 17, 2024 … solutions, today announced the successful exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024
8-K
INBS
Intelligent Bio Solutions Inc
20 May 24
Regulation FD Disclosure
5:00pm
”) announcing the successful exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024.
A copy of the Press
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
8 May 24
Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
4:30pm
, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test
8-K
EX-99.1
a6re0jhclz ff
18 Apr 24
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
440km8el
12 Apr 24
Regulation FD Disclosure
8:30am
424B3
9hl6tv7
28 Mar 24
Prospectus supplement
9:00am
424B3
oy11ix
18 Mar 24
Prospectus supplement
1:09pm
8-K
EX-10.1
z40 199pwse
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
gfpprjab91291m3 7i
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.2
h9nnia5g
12 Mar 24
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30pm
8-K
EX-99.1
821p4 wbn
29 Feb 24
Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) Pathway
5:00pm
8-K
EX-99.1
yq70vi6e bka
20 Feb 24
Other Events
5:05pm
8-K
EX-99.1
0kfmxeea a1rg
9 Feb 24
Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights
5:05pm
8-K
EX-99.1
kvux 4dxhd1
7 Feb 24
Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross Proceeds
5:05pm